Literature DB >> 30546746

Donepezil-induced torsades de pointes without QT prolongation.

Yasuyuki Hadano1, Hiroshi Ogawa1, Takatoshi Wakeyama1, Takahiro Iwami1, Masayasu Kimura1, Mamoru Mochizuki1, Shintaro Akashi1, Yosuke Miyazaki1, Tadaaki Nakashima1, Akihiko Shimizu2.   

Abstract

We report a case of torsades de pointes (TdP) induced by donepezil without QT prolongation. An 86-year-old woman was admitted to our hospital because of a syncopal attack. She had been treated for Alzheimer's disease with donepezil. Initial 12-lead electrocardiogram showed atrial fibrillation and normal corrected QT interval. After admission, atrial fibrillation spontaneously recovered to normal sinus rhythm on electrocardiographic monitoring. On the second day, electrocardiographic monitoring documented TdP. We discontinued donepezil immediately. After washout of donepezil, TdP was not observed again. Corrected QT interval was normal throughout hospitalization. This case suggests that donepezil may cause life-threatening ventricular arrhythmias without QT prolongation. Even if corrected QT interval is normal in patients taking donepezil and experiencing symptoms associated with TdP, electrocardiographic monitoring is recommended. <Learning objective: Donepezil may cause life-threatening ventricular arrhythmias without QT prolongation. Even if corrected QT interval is normal in patients taking donepezil and experiencing symptoms associated with torsades de pointes, electrocardiographic monitoring is recommended.>.

Entities:  

Keywords:  Arrhythmias; QT interval; Ventricular arrhythmia

Year:  2013        PMID: 30546746      PMCID: PMC6281504          DOI: 10.1016/j.jccase.2013.05.004

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  3 in total

Review 1.  Correlation Between Donepezil and QTc Prolongation and Torsades de Pointes: A Very Rare Phenomenon.

Authors:  Bilal Haider Malik; Pousette Hamid; Safeera Khan; Deepti Gupta; Muhammad Islam
Journal:  Cureus       Date:  2019-12-23

Review 2.  QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative Review.

Authors:  Yasar Torres-Yaghi; Amelia Carwin; Jacob Carolan; Steven Nakano; Fahd Amjad; Fernando Pagan
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-24       Impact factor: 2.570

Review 3.  Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias - A narrative review.

Authors:  Yichang Huang; Mhd Wasem Alsabbagh
Journal:  Pharmacol Res Perspect       Date:  2020-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.